会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • UDP-N-ACETYL GLUCOSAMINYL: beta 1,4 GALACTOSIDE: beta 1,3N-ACETYL GLUCOSAMINYL TRANSFERASE (POLYLACTOSAMINYL TYPE)
    • UDP-N-乙酰GLUKOSAMINYL:β-1,4半乳糖:测试1.3N乙酰GLUKOSAMINYL转移酶(POLYLAKTOSAMINYL TYPE)
    • WO0011190A2
    • 2000-03-02
    • PCT/CH9900365
    • 1999-08-06
    • BERGER ERIC GHENNET THIERRY
    • BERGER ERIC GHENNET THIERRY
    • C12N9/10C12N15/54C12P19/26
    • C12N9/1051C12P19/26
    • The invention relates to a new gene which codes for UDP-N-acetyl glucosaminyl: beta 1,4 galactoside: beta 1,3(N-acetyl glucosaminyl transferase (3GnT). Its enzymatic activity and specificity differ from those of all glycosyl transferases published so far. The invention further relates to isolated DNA molecules and constructs, including their derivatives, which code for 3GnT (referred to as 3GnT-DNA), cloning and expression vectors containing the above 3GnT-DNA, cells transfected with said vectors and recombination methods for obtaining said DNA. The invention also relates to a method for the synthesis of di-, oligo- and polysaccharides with the repetitive element N-acetyl glucosamine ( beta 1}3)galactose( beta 1}4) by obtaining and using the recombinant enzyme from transfected cells which were transfected with 3GnT-DNA, including its derivatives. The invention also relates to methods for diagnosing genetic changes in animals and humans and to the production of antisense samples and targeting vectors for producing transgenic animals.
    • 本发明是用于对UDP-N- Acetylglukosaminyl一个新的基因编码:1.4的β半乳糖苷:β-内1.3N Acetylglukosaminyltransferase(3GnT)编码。 酶活性和特异性不同于所有以前公布的糖基转移酶。 本发明包括转染用这些载体的分离的DNA分子和构建体,包括它们的衍生物,其编码的3GnT(下文3GnT DNA),以及含有这些DNA 3GnT,克隆和表达载体,以及细胞 以及重组该DNA的方法。 本发明还(4测试1})通过从与3GnT-处理的转染的细胞提取和重组酶的应用涉及用于二糖,寡糖和与重复元件N-乙酰葡糖胺多糖(测试1} 3)半乳糖的合成方法 转染DNA及其衍生物。 本发明还包括用于诊断动物和人的遗传改变的方法,用于生产基因修饰动物的反义样品和“靶向”载体的生产。